The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis-Reference-Cited by-同舟云学术

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis

Published:2014 Issue:1 Volume:32 Page:28
ISSN:2287-4208
Container-title:The World Journal of Men's Health
language:en
Short-container-title:World J Mens Health

Author:

Lee Sung Won¹,Paick Jae Seung²,Park Hyun Jun³,Won Ji Eon⁴,Morisaki Yoji⁵,Sorsaburu Sebastian⁶,Viktrup Lars⁶

Affiliation:

1. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Department of Urology, Seoul National University Hospital, Seoul, Korea.

3. Department of Urology, Pusan National University Hospital, Medical Research Institute, Pusan National University School of Medicine, Busan, Korea.

4. Eli Lilly Korea, Seoul, Korea.

5. Eli Lilly Japan K.K., Kobe, Japan.

6. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Funder

Eli Lilly and Company

Publisher

Korean Society for Sexual Medicine and Andrology

Subject

Pharmacology (medical),Urology,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Policy,Aging,Reproductive Medicine

Link

https://synapse.koreamed.org/pdf/10.5534/wjmh.2014.32.1.28

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effectiveness and safety of a daily dose of 5 mg of tadalafil, over an 8-week period, for improving quality of life among Korean men with andropause symptoms, including erectile dysfunction;Medicine;2018-12

2. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia;Cochrane Database of Systematic Reviews;2018-11-16

3. Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study;International Journal of Urology;2018-10-25

4. Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model;Drug Design, Development and Therapy;2018-06

5. Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study;The World Journal of Men's Health;2018